YARW
Yarrow Bioscience Inc
20.30$
-8.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +50.0% | +0.0% | +0.0% | -16.7% | -340.0% | – | – | |
| – | -17.7% | +38.7% | -10.2% | -17.1% | -4.8% | +9.2% | -30.7% | -7.9% | +8.6% | -10.4% | -8.0% | – | |
| – | +4.6% | -425.9% | – | +421.8% | -16.2% | -215.0% | – | – | – | -252.3% | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | -94.3% | – | -125.4% | – | +55.7% | -76.4% | -5.8% | +92.2% | -44.4% | -93.6% | – | |
| – | – | – | – | – | – | – | – | -79.4% | +114.3% | – | – | – | |
| – | – | -100.0% | -60.0% | +0.0% | +6,500.0% | -34.1% | -60.9% | -79.4% | +114.3% | +0.0% | -6.7% | – | |
| – | – | -176.2% | – | -226.6% | – | +129.6% | -174.4% | – | – | -87.1% | -382.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.